Items where authors include "Grabsch, HI"
Up a levelArticle
Niehues, JM, Quirke, P orcid.org/0000-0002-3597-5444, West, NP orcid.org/0000-0002-0346-6709 et al. (16 more authors) (2023) Generalizable biomarker prediction from cancer pathology slides with self-supervised deep learning: A retrospective multi-centric study. Cell Reports Medicine, 4 (4). 100980. ISSN 2666-3791
Saldanha, OL, Quirke, P orcid.org/0000-0002-3597-5444, West, NP orcid.org/0000-0002-0346-6709 et al. (24 more authors) (2022) Swarm learning for decentralized artificial intelligence in cancer histopathology. Nature Medicine, 28. pp. 1232-1239. ISSN 1078-8956
West, N orcid.org/0000-0002-0346-6709, Echle, A, Laleh, NG et al. (35 more authors) (2022) Artificial intelligence for detection of microsatellite instability in colorectal cancer – a multicentric analysis of a pre-screening tool for clinical application. ESMO Open, 7 (2). ISSN 2059-7029
Schrammen, PL, Laleh, NG, Echle, A et al. (16 more authors) (2022) Weakly supervised annotation-free cancer detection and prediction of genotype in routine histopathology. Journal of Pathology, 256 (1). pp. 50-60. ISSN 0022-3417
Echle, A, Laleh, NG, Schrammen, PL et al. (9 more authors) (2021) Deep Learning for the detection of microsatellite instability from histology images in colorectal cancer: a systematic literature review. ImmunoInformatics, 3-4. 100008. ISSN 2667-1190
Muti, HS, Heij, LR, Keller, G et al. (32 more authors) (2021) Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study. The Lancet Digital Health, 3 (10). e654-e664. ISSN 2589-7500
Hall, PS, Swinson, D, Cairns, DA orcid.org/0000-0002-2338-0179 et al. (32 more authors) (2021) Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial. JAMA oncology, 7 (6). pp. 869-877. ISSN 2374-2437
Krause, J, Grabsch, HI orcid.org/0000-0001-9520-6228, Kloor, M et al. (13 more authors) (2021) Deep learning detects genetic alterations in cancer histology generated by adversarial networks. The Journal of Pathology, 254 (1). pp. 70-79. ISSN 0022-3417
Koemans, WJ, Larue, RTHM, Kloft, M et al. (10 more authors) (2021) Lymph node response to chemoradiotherapy in oesophageal cancer patients: relationship with radiotherapy fields. Esophagus, 18 (1). pp. 100-110. ISSN 1612-9059
Sundar, R, Liu, DHW, Hutchins, GGA et al. (11 more authors) (2020) Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination. Gut. ISSN 0017-5749
Echle, A, Grabsch, HI orcid.org/0000-0001-9520-6228, Quirke, P orcid.org/0000-0002-3597-5444 et al. (20 more authors) (2020) Clinical-grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning. Gastroenterology, 159 (4). 1406-1416.e11. ISSN 0016-5085
Athauda, A, Nankivell, M, Langley, RE et al. (6 more authors) (2020) Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03). European Journal of Cancer, 137. pp. 45-56. ISSN 0959-8049
Ruisch, JE, Kloft, M, Fazzi, GE et al. (3 more authors) (2020) Large negative lymph nodes – a surrogate for immune activation in rectal cancer patients? Pathology, Research and Practice, 216 (9). 153106. ISSN 0344-0338
Kerckhoffs, KGP, Liu, DHW, Saragoni, L et al. (17 more authors) (2020) Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer. Gastric Cancer, 23 (5). pp. 765-779. ISSN 1436-3291
Smyth, EC, Nilsson, M, Grabsch, HI orcid.org/0000-0001-9520-6228 et al. (2 more authors) (2020) Gastric cancer. The Lancet, 396 (10251). pp. 635-648. ISSN 0140-6736
Davarzani, N, Hewitt, LC, Hale, MD et al. (8 more authors) (2020) Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial. Diseases of the Esophagus, 33 (8). doaa058. ISSN 1120-8694
Xing, M, Ooi, WF, Tan, J et al. (43 more authors) (2020) Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer. Journal of Clinical Investigation. ISSN 0021-9738
Verrijssen, A, Guillem, J, Perez, R et al. (14 more authors) (2020) Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: a meta-analysis based on individual patient data. Radiotherapy and Oncology, 144. pp. 37-45. ISSN 0167-8140
Tan, SH, Swathi, Y, Tan, S et al. (21 more authors) (2020) AQP5 enriches for stem cells and cancer origins in the distal stomach. Nature, 578 (7795). pp. 437-443. ISSN 0028-0836
Klaver, CEL, Bulkmans, N, Drillenburg, P et al. (13 more authors) (2020) Interobserver, intraobserver, and interlaboratory variability in reporting pT4a colon cancer. Virchows Archiv, 476 (2). pp. 219-230. ISSN 0945-6317
Wagner, AD, Lordick, F, Grabsch, HI orcid.org/0000-0001-9520-6228 et al. (9 more authors) (2020) Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer. European Journal of Cancer, 124. pp. 67-76. ISSN 0959-8049
de Vos-Geelen, J, Hoebers, FJP, Geurts, SME et al. (18 more authors) (2020) A national study to assess outcomes of definitive chemoradiation regimens in proximal esophageal cancer. Acta Oncologica, 59 (8). pp. 895-903. ISSN 0284-186X
de Vos-Geelen, J, Geurts, SM, van Putten, M et al. (13 more authors) (2019) Trends in treatment and overall survival among patients with proximal esophageal cancer. World Journal of Gastroenterology, 25 (47). pp. 6835-6846. ISSN 1007-9327
Pietrantonio, F, Miceli, R, Raimondi, A et al. (21 more authors) (2019) Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. Journal of Clinical Oncology, 37 (35). pp. 3392-3400. ISSN 0732-183X
Sundar, R, Ng, A, Zouridis, H et al. (18 more authors) (2019) DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial. European Journal of Cancer, 123. pp. 48-57. ISSN 0959-8049
Hewitt, LC, Saito, Y, Wang, T et al. (10 more authors) (2019) Correction to: KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study. Gastric Cancer, 22 (6). pp. 1204-1205. ISSN 1436-3291
Hewitt, LC, Saito, Y, Wang, T et al. (10 more authors) (2019) KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study. Gastric Cancer, 22 (6). pp. 1193-1203. ISSN 1436-3291
Yoshikawa, T, Aoyama, T, Sakamaki, K et al. (19 more authors) (2019) Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer. Journal of Cancer, 10 (21). pp. 5130-5138. ISSN 1837-9664
de Santiago, I, Yau, C, Heij, L et al. (5 more authors) (2019) Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes. International Journal of Cancer, 145 (4). pp. 1125-1137. ISSN 0020-7136
Allum, WH, Smyth, EC, Blazeby, JM et al. (6 more authors) (2019) Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro‐oesophageal junction. British Journal of Surgery, 106 (9). pp. 1204-1215. ISSN 0007-1323
Coelho-Barros, EA, Achcar, JA, Martinez, EZ et al. (2 more authors) (2019) Bayesian Inference For The Segmented Weibull Distribution. Revista Colombiana de Estadistica, 42 (2). pp. 225-243. ISSN 0120-1751
Kather, JN, Pearson, AT, Halama, N et al. (14 more authors) (2019) Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nature Medicine, 25 (7). pp. 1054-1056. ISSN 1078-8956
Smyth, EC, Rowley, S, Cafferty, FH et al. (17 more authors) (2019) Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical Trial. JAMA Oncology, 5 (8). pp. 1181-1187. ISSN 2374-2437
van der Sande, ME, Beets, GL, Hupkens, BJP et al. (7 more authors) (2019) Response assessment after (chemo)radiotherapy for rectal cancer: Why are we missing complete responses with MRI and endoscopy? European Journal of Surgical Oncology, 45 (6). pp. 1011-1017. ISSN 0748-7983
van Dijk, DPJ, Horstman, AMH, Smeets, JSJ et al. (6 more authors) (2019) Tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer. Journal of Cachexia, Sarcopenia and Muscle, 10 (3). pp. 549-556. ISSN 2190-5991
Wagner, AD, Grabsch, HI orcid.org/0000-0001-9520-6228, Mauer, M et al. (12 more authors) (2019) EORTC-1203-GITCG - the “INNOVATION”-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group. BMC Cancer, 19. 494. ISSN 1471-2407
Lutz, MP, Zalcberg, JR, Ducreux, M et al. (21 more authors) (2019) The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma. European Journal of Cancer, 112. pp. 1-8. ISSN 0959-8049
Mariette, C, Carneiro, F, Grabsch, HI orcid.org/0000-0001-9520-6228 et al. (4 more authors) (2019) Correction to: Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer, 22 (2). p. 421. ISSN 1436-3291
Mariette, C, Carneiro, F, Grabsch, HI et al. (3 more authors) (2019) Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer, 22 (1). pp. 1-9. ISSN 1436-3291
Urbanowicz, M, Grabsch, HI orcid.org/0000-0001-9520-6228, Fiteni, F et al. (3 more authors) (2018) An international survey-based study on colorectal cancer pathology reporting—guidelines versus local practice. Virchows Archiv, 473 (6). pp. 697-708. ISSN 0945-6317
Leung, CAW, Fazzi, G, Melenhorst, J et al. (2 more authors) (2018) Acetone clearance of the mesocolic and mesorectal fat increases lymph node yield and may improve detection of high risk stage II colorectal cancer. Colorectal Disease, 20 (11). pp. 1014-1019. ISSN 1463-1318
Slagter, AE, Jansen, EPM, van Laarhoven, HWM et al. (19 more authors) (2018) CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer. BMC Cancer, 18. 877. ISSN 1471-2407
Davarzani, N, Hutchins, GGA orcid.org/0000-0002-1707-4415, West, NP orcid.org/0000-0002-0346-6709 et al. (8 more authors) (2018) Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – results from the MRC OE02 oesophageal cancer trial. Histopathology, 72 (7). pp. 1180-1188. ISSN 0309-0167
Hewitt, LC, Inam, IZ, Saito, Y et al. (12 more authors) (2018) Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study. European Journal of Cancer, 94. pp. 104-114. ISSN 0959-8049
Hutchins, G orcid.org/0000-0002-1707-4415 and Grabsch, HI (2018) How to make tissue microarrays. Diagnostic Histopathology, 24 (4). pp. 127-135. ISSN 1756-2317
Draht, MXG, Goudkade, D, Koch, A et al. (5 more authors) (2018) Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. Clinical Epigenetics, 10. 35. ISSN 1868-7075
Silva, ANS, Coffa, J, Menon, V et al. (19 more authors) (2018) Frequent Coamplification of Receptor Tyrosine Kinase and Downstream Signaling Genes in Japanese Primary Gastric Cancer and Conversion in Matched Lymph Node Metastasis. Annals of Surgery, 267 (1). pp. 114-121. ISSN 0003-4932
Alderson, D, Cunningham, D, Nankivell, M et al. (14 more authors) (2017) Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial. Lancet Oncology, 18 (9). pp. 1249-1260. ISSN 1470-2045
Nerad, E, Lambregts, DMJ, Kersten, ELJ et al. (6 more authors) (2017) MRI for Local Staging of Colon Cancer: Can MRI Become the Optimal Staging Modality for Patients With Colon Cancer? Diseases of the Colon and Rectum, 60 (4). pp. 385-392. ISSN 0012-3706
Mukherjee, S, Hurt, CN, Gwynne, S et al. (15 more authors) (2017) NEOSCOPE: A randomized phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. European Journal of Cancer, 74. pp. 38-46. ISSN 0959-8049
Cunningham, D, Stenning, SP, Smyth, EC et al. (15 more authors) (2017) Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial. Lancet Oncology, 18 (3). pp. 357-370. ISSN 1470-2045
Hale, MD, Nankivell, M, Hutchins, GG et al. (11 more authors) (2016) Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma –results from the UK MRC OE02 trial. Oncotarget, 7 (47). pp. 77565-77575. ISSN 1949-2553
van der Post, RS, Gullo, I, Oliveira, C et al. (6 more authors) (2016) Erratum to: Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future. Advances in Experimental Medicine and Biology, 908. E1. ISSN 0065-2598
Hoeben, A, Polak, J, Van De Voorde, L et al. (3 more authors) (2016) Cervical esophageal cancer: a gap in cancer knowledge. Annals of Oncology, 27 (9). pp. 1664-1674. ISSN 0923-7534
Smyth, EC, Fassan, M, Cunningham, D et al. (13 more authors) (2016) Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial. Journal of Clinical Oncology, 34 (23). pp. 2721-2727. ISSN 0732-183X
Hendrikx, T, Watzenböck, ML, Walenbergh, SMA et al. (13 more authors) (2016) Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease. BMC Medicine, 14 (1). 107. ISSN 1741-7015
Bain, GH, Collie-Duguid, E, Murray, GI et al. (18 more authors) (2016) Erratum: Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas. British Journal of Cancer, 114 (12). e18-e18. ISSN 0007-0920
Obulkasim, A, Yistra, B, Van Essen, HF et al. (11 more authors) (2016) Reduced genomic tumor heterogeneity after neoadjuvat chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma. Oncotarget, 7 (28). pp. 44084-44095. ISSN 1949-2553
Moehler, M, Delic, M, Goepfert, K et al. (14 more authors) (2016) Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives. European Journal of Cancer, 59. pp. 160-170. ISSN 0959-8049
Tominaga, N, Gotoda, T, Hara, M et al. (9 more authors) (2016) Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer. Gastric Cancer, 19 (2). pp. 553-560. ISSN 1436-3291
Rohwer, N, Bindel, F, Grimm, C et al. (15 more authors) (2015) Annexin A1 sustains tumor metabolism and cellular proliferation upon stable loss of HIF1A. Oncotarget, 7 (6). pp. 6693-6710.
Lin, SJ, Gagnon-Bartsch, JA, Tan, IB et al. (28 more authors) (2015) Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas. Gut, 64 (11). pp. 1721-1731. ISSN 0017-5749
Feilchenfeldt, J, Varga, Z, Siano, M et al. (19 more authors) (2015) Brain metastases in gastro-oesophageal adenocarcinoma: Insights into the role of the human epidermal growth factor receptor 2 (HER2). British Journal of Cancer, 113 (5). pp. 716-721. ISSN 0007-0920
Mukherjee, S, Hurt, CN, Gwynne, S et al. (16 more authors) (2015) NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC Cancer, 15 (1). ARTN 48. ISSN 1471-2407
Bain, GH, Collie-Duguid, E, Murray, GI et al. (18 more authors) (2014) Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas. British Journal of Cancer, 110 (6). pp. 1525-1534. ISSN 0007-0920
Su, X, Zhan, P, Gavine, PR et al. (10 more authors) (2014) FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study. British Journal of Cancer, 110 (4). pp. 967-975. ISSN 0007-0920
van Grieken, NCT, Aoyama, T, Chambers, PA orcid.org/0000-0002-0926-717X et al. (19 more authors) (2013) KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study. British Journal of Cancer, 108 (7). pp. 1495-1501. ISSN 0007-0920
Belien, JAM, Buffart, TE, Gill, AJ et al. (4 more authors) (2009) Gross genomic damage measured by DNA image cytometry independently predicts gastric cancer patient survival. British Journal of Cancer, 101 (6). pp. 1011-1018. ISSN 0007-0920
Buffart, TE, van Grieken, NCT, Tijssen, M et al. (6 more authors) (2009) High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers. Virchows Archiv, 455 (3). pp. 213-223. ISSN 0945-6317
Buffart, TE, Overmeer, RM, Steenbergen, RDM et al. (7 more authors) (2008) MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. British Journal of Cancer, 99 (11). pp. 1802-1807. ISSN 0007-0920
Proceedings Paper
Kerckhoffs, KGP, Liu, DHW, Hewitt, LC et al. (2 more authors) (2019) Alcian Blue: A Rediscovered Biomarker of Poor Prognosis in Gastric Cancer Patients. In: Journal of Pathology. Leeds Pathology 2019: 12th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 02-04 Jul 2019, Leeds, UK. Wiley .
Ruisch, JE, Melenhorst, J and Grabsch, HI orcid.org/0000-0001-9520-6228 (2019) Differences in Negative Lymph Node Size in Rectal Cancer Resections are Related to Patient's Immune Reaction. In: Journal of Pathology. Leeds Pathology 2019: 12th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 02-04 Jul 2019, Leeds, UK. Wiley , S37.
Athauda, A, Nankivell, MG, Langley, RE et al. (17 more authors) (2019) Impact of age and sex on chemotherapy (CTx) efficacy, toxicity and survival in early oesophagogastric (OG) cancer: A pooled analysis of 3265 patients from four large randomised trials (OE02, OE05, MAGIC & ST03). In: Journal of Clinical Oncology. Annual Meeting of the American Society of Clinical Oncology (ASCO), 31 May - 04 Jun 2019, Chicago, IL, USA. American Society of Clinical Oncology (ASCO) .
Hall, PS, Swinson, D, Waters, JS et al. (17 more authors) (2019) Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial. In: Journal of Clinical Oncology. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 31 May - 04 Jun 2019, Chicago, USA. American Society of Clinical Oncology .
Gurtekin, I, Kamps, I, Kemper, S et al. (7 more authors) (2019) Honours Student's Professional Competencies Improved Significantly by Organizing a Full Day Programme at an International Pathology Meeting. In: Journal of Pathology. Meeting of the Pathological Society of Great Britain & Ireland, 22-23 Jan 2019, London, UK. Wiley , S8.
Meier, A, Nekolla, K, Earle, S et al. (6 more authors) (2018) End-to-end learning to predict survival in patients with gastric cancer using convolutional neural networks. In: Annals of Oncology. ESMO 2018, 19-23 Oct 2018, Munich, Germany. Oxford University Press , p. 23.
Hutchins, GGA orcid.org/0000-0002-1707-4415, Davarzani, N, West, NP orcid.org/0000-0002-0346-6709 et al. (8 more authors) (2018) Defining the Clinical Value of Pathological Lymph Node Status and Primary Tumour Regression Grading Following Neoadjuvant Therapy in Oesophageal Cancer: Results from the MRC OE02 Trial. In: Journal of Pathology. Maastricht Pathology 2018: 11th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 19-22 Jun 2018, Maastricht, the Netherlands. Wiley , S16-S16.
Kloft, M, Ruisch, J, Raghuram, G et al. (2 more authors) (2018) Largest Negative Lymph Node Diameter: A Novel Predictor of Good Prognosis in Patients with Oesophageal Cancer. In: Journal of Pathology. Maastricht Pathology 2018: 11th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 19-22 Jun 2018, Maastricht, the Netherlands. Wiley , S30-S30.
Koemans, WJ, Larue, RTH, Compter, I et al. (7 more authors) (2018) Lymph Node Response to Chemoradiotherapy in Oesophageal Cancer Patients: Relationship with Current Guidelines for Elective Lymph Node Irradiation. In: Journal of Pathology. Maastricht Pathology 2018: 11th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 19-22 Jun 2018, Maastricht, the Netherlands. Wiley , S31-S31.
Hewitt, LC, Saito, Y, Hutchins, G et al. (8 more authors) (2018) Relationship Between KRAS Activation and Histological Phenotype in Gastric Cancer. In: Journal of Pathology. Maastricht Pathology 2018: 11th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 19-22 Jun 2018, Maastricht, the Netherlands. Wiley , S30-S30.
Häller, M, Fazzi, GE, Clarke, E et al. (2 more authors) (2018) Towards High-Throughput Lymphocyte Quantification in Haematoxylin Eosin Stained Biopsy Sections by Establishing an Image Analysis Pipeline. In: Journal of Pathology. Maastricht Pathology 2018: 11th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 19-22 Jun 2018, Maastricht, the Netherlands. Wiley , S31-S31.
Yigitsoy, M, Earle, S, Meier, A et al. (7 more authors) (2017) Abstract 3958: The importance of co-localized resting CD8+ T cells and proliferating tumor cells in gastric cancer. In: Cancer Research. AACR Annual Meeting 2017, 01-05 Apr 2017, Washington, DC, USA. American Association for Cancer Research , p. 3958.